PRCT | PROCEPT BioRobotics Corporation | [NASD]
Index- P/E- EPS (ttm)-2.20 Insider Own0.30% Shs Outstand44.77M Perf Week-6.30%
Market Cap1.43B Forward P/E- EPS next Y-1.71 Insider Trans-50.43% Shs Float42.98M Perf Month3.32%
Income-98.50M PEG- EPS next Q-0.57 Inst Own74.90% Short Float / Ratio5.11% / 5.40 Perf Quarter-16.15%
Sales85.20M P/S16.73 EPS this Y-43.20% Inst Trans-7.10% Short Interest2.20M Perf Half Y-30.99%
Book/sh4.40 P/B7.14 EPS next Y21.90% ROA-24.40% Target Price49.86 Perf Year-23.13%
Cash/sh4.89 P/C6.42 EPS next 5Y- ROE-34.00% 52W Range25.29 - 52.40 Perf YTD-24.41%
Dividend- P/FCF- EPS past 5Y- ROI-33.80% 52W High-40.08% Beta-
Dividend %- Quick Ratio6.90 Sales past 5Y- Gross Margin49.10% 52W Low24.16% ATR1.81
Employees428 Current Ratio7.70 Sales Q/Q135.60% Oper. Margin-85.20% RSI (14)47.98 Volatility4.72% 5.52%
OptionableYes Debt/Eq0.26 EPS Q/Q-51.90% Profit Margin-90.70% Rel Volume0.72 Prev Close31.85
ShortableYes LT Debt/Eq0.26 EarningsApr 27 BMO Payout- Avg Volume407.26K Price31.40
Recom2.00 SMA201.71% SMA50-1.23% SMA200-18.41% Volume294,551 Change-1.41%
Date Action Analyst Rating Change Price Target Change
Oct-31-22Initiated BTIG Research Neutral
Oct-25-22Initiated Truist Buy $58
Sep-02-22Initiated Wells Fargo Overweight $49
Jul-15-22Initiated KeyBanc Capital Markets Overweight $47
Jun-23-22Initiated B. Riley Securities Buy $53
Oct-11-21Initiated SVB Leerink Outperform $46
Oct-11-21Initiated Guggenheim Buy $45
Oct-11-21Initiated Goldman Neutral $37
Oct-11-21Initiated Cowen Outperform $50
Oct-11-21Initiated BofA Securities Buy $48
May-17-23 06:12AM
May-14-23 02:57PM
Apr-28-23 08:00AM
Apr-27-23 12:52PM
07:00AM Loading…
Apr-24-23 10:00AM
Apr-20-23 10:03AM
Apr-06-23 06:33AM
Apr-05-23 04:03PM
Apr-03-23 08:00AM
Mar-30-23 04:05PM
Mar-27-23 08:08AM
Mar-07-23 07:00AM
Mar-02-23 04:05PM
09:52AM Loading…
Mar-01-23 09:52AM
Feb-28-23 05:25PM
Feb-22-23 05:33AM
Feb-16-23 09:15AM
Feb-13-23 04:02PM
Jan-09-23 08:00AM
Dec-14-22 04:05PM
Dec-12-22 03:44PM
Nov-09-22 07:32AM
Nov-03-22 05:55PM
Oct-27-22 10:02AM
Oct-12-22 08:00AM
08:00AM Loading…
Oct-10-22 08:00AM
Oct-04-22 10:15AM
Oct-03-22 09:16AM
Sep-19-22 08:00AM
Sep-15-22 06:15AM
Aug-22-22 04:03PM
Aug-05-22 05:30PM
Aug-04-22 04:03PM
Jul-14-22 04:02PM
Jul-10-22 08:32AM
Jun-16-22 02:30PM
Jun-09-22 09:01AM
May-10-22 06:20AM
May-05-22 04:02PM
Apr-28-22 08:00AM
Apr-12-22 04:02PM
Apr-11-22 08:00AM
Mar-10-22 06:03AM
Mar-08-22 04:00PM
Feb-22-22 08:00AM
Feb-14-22 04:03PM
Feb-01-22 04:03PM
Jan-31-22 01:38PM
Jan-18-22 10:11AM
Jan-14-22 12:37PM
Jan-11-22 04:03PM
Jan-06-22 10:18AM
Jan-04-22 07:00AM
Dec-15-21 08:04AM
Dec-14-21 05:38PM
Nov-05-21 12:01PM
Nov-04-21 04:03PM
Oct-26-21 07:00AM
Oct-21-21 04:04PM
Sep-28-21 07:00AM
Sep-21-21 04:05PM
Sep-17-21 05:28AM
Sep-15-21 12:12PM
Sep-14-21 07:03PM
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nouri AlalehEVP, CLO, CORP. SEC.May 08Option Exercise4.5212,12354,79646,933May 10 04:41 PM
Zadno RezaPresident, CEOApr 28Option Exercise4.3719,99587,378195,808May 02 05:13 PM
Shiblaq HishamEVP, Chief Comm. OfficerApr 11Sale35.2321,930772,51531,414Apr 12 04:15 PM
Zadno RezaPresident, CEOApr 04Option Exercise4.3720,02287,496175,813Apr 05 05:33 PM
Zadno RezaPresident, CEOMar 16Sale31.845,335169,866155,791Mar 17 03:55 PM
Waters KevinEVP, CFOMar 16Sale31.8470622,47956,154Mar 17 03:54 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 16Sale31.843049,67934,810Mar 17 03:51 PM
Shiblaq HishamEVP, Chief Comm. OfficerMar 16Sale31.842467,83353,344Mar 17 03:52 PM
Nouri AlalehEVP, CLO, CORP. SEC.Mar 08Option Exercise4.5210,00045,20035,114Mar 09 05:22 PM
Waters KevinEVP, CFOMar 08Sale34.3622,046757,54757,678Mar 09 05:24 PM
Waters KevinEVP, CFOMar 07Sale34.257,954272,46356,860Mar 09 05:24 PM
Wood Morgan ColbyDirectorMar 03Sale36.1415,000542,159134,714Mar 06 04:59 PM
Shiblaq HishamEVP, Chief Comm. OfficerJan 04Sale39.7446618,52127,275Jan 05 04:09 PM
Shiblaq HishamEVP, Chief Comm. OfficerJan 03Sale40.5221,463869,68927,741Jan 05 04:09 PM
Nouri AlalehEVP, CLO, CORP. SEC.Dec 27Sale40.903,064125,3084,062Dec 28 04:06 PM
Nouri AlalehEVP, CLO, CORP. SEC.Dec 19Sale43.2320,000864,5947,126Dec 20 04:53 PM
Nouri AlalehEVP, CLO, CORP. SEC.Dec 16Sale41.9720,000839,34827,126Dec 20 04:53 PM
Krummel Thomas MDirectorJun 22Option Exercise4.512,68912,134102,920Jun 22 07:11 PM
Krummel Thomas MDirectorJun 21Option Exercise2.5917,31144,773100,231Jun 22 07:11 PM
Krummel Thomas MDirectorJun 21Sale35.9820,000719,65382,920Jun 22 07:11 PM